Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Xoma Royalty Corporation (XOMA)

Xoma Royalty Corporation (XOMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 385,483
  • Shares Outstanding, K 12,383
  • Annual Sales, $ 28,490 K
  • Annual Income, $ -13,820 K
  • EBIT $ 4 M
  • EBITDA $ 4 M
  • 60-Month Beta 0.94
  • Price/Sales 13.48
  • Price/Cash Flow N/A
  • Price/Book 4.26

Options Overview Details

View History
  • Implied Volatility 63.83% (+63.83%)
  • Historical Volatility 37.71%
  • IV Percentile 16%
  • IV Rank 30.34%
  • IV High 110.71% on 04/01/25
  • IV Low 43.42% on 08/18/25
  • Expected Move (DTE 14) 2.13 (7.14%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 25
  • Volume Avg (30-Day) 9
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 89
  • Open Int (30-Day) 774
  • Expected Range 27.63 to 31.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.06
  • Number of Estimates 3
  • High Estimate 0.24
  • Low Estimate -0.29
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +86.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.07 +2.68%
on 12/03/25
34.94 -14.58%
on 11/11/25
-3.54 (-10.59%)
since 11/05/25
3-Month
29.07 +2.68%
on 12/03/25
39.92 -25.24%
on 10/03/25
-5.40 (-15.31%)
since 09/05/25
52-Week
18.35 +62.63%
on 04/07/25
39.92 -25.24%
on 10/03/25
-0.28 (-0.95%)
since 12/05/24

Most Recent Stories

More News
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc

EMERYVILLE, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA), the biotech royalty aggregator, today announced it has successfully completed its previously...

XOMA : 29.83 (-4.18%)
XOMAP : 26.50 (-0.67%)
XOMAO : 25.43 (+0.79%)
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition

WALTHAM, Mass. and DUBLIN, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) (“ Mural ”) announces that the scheme of arrangement between Mural and its shareholders under Chapter...

XOMA : 29.83 (-4.18%)
MURA : 2.04 (unch)
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty

WALTHAM, Mass. and DUBLIN, Ireland, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA) (“ Mural ”) announces that, in accordance with the terms of the transaction agreement between...

XOMA : 29.83 (-4.18%)
MURA : 2.04 (unch)
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.

EMERYVILLE, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) today announced it has successfully completed its previously announced acquisition of...

XOMA : 29.83 (-4.18%)
XOMAP : 26.50 (-0.67%)
XOMAO : 25.43 (+0.79%)
LVTX : 1.7400 (-3.87%)
XOMA Royalty: Q3 Earnings Snapshot

XOMA Royalty: Q3 Earnings Snapshot

XOMA : 29.83 (-4.18%)
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

Business development : Secures royalty economic interests in two early stage partnered assets through XOMA Royalty’s announced expected acquisition of LAVA Therapeutics. Company acquisitions...

XOMA : 29.83 (-4.18%)
XOMAP : 26.50 (-0.67%)
XOMAO : 25.43 (+0.79%)
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION ...

XOMA : 29.83 (-4.18%)
MURA : 2.04 (unch)
XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

- Amendment includes finalized cash amount and updated CVR terms for tender offer - LAVA announces new date for extraordinary general meeting of shareholders EMERYVILLE, Calif. and UTRECHT, The...

XOMA : 29.83 (-4.18%)
XOMAP : 26.50 (-0.67%)
XOMAO : 25.43 (+0.79%)
LVTX : 1.7400 (-3.87%)
Xoma Announces $125 Million Sales Agreements

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...

XOMA : 29.83 (-4.18%)
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.

EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”)...

XOMA : 29.83 (-4.18%)
XOMAP : 26.50 (-0.67%)
XOMAO : 25.43 (+0.79%)
LVTX : 1.7400 (-3.87%)

Business Summary

XOMA ROYALTY is a biotechnology royalty aggregator. The company acquires the potential future economics associated with pre-commercial therapeutic candidates which have been licensed to pharmaceutical or biotechnology companies. XOMA ROYALTY, formerly known as XOMA Corporation, is based in EMERYVILLE,...

See More

Key Turning Points

3rd Resistance Point 32.74
2nd Resistance Point 32.09
1st Resistance Point 31.61
Last Price 29.83
1st Support Level 30.48
2nd Support Level 29.83
3rd Support Level 29.35

See More

52-Week High 39.92
Fibonacci 61.8% 31.68
Last Price 29.83
Fibonacci 50% 29.14
Fibonacci 38.2% 26.59
52-Week Low 18.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar